ETF Managers Group, LLC Exelixis, Inc. Transaction History

ETF Managers Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $1.34 Million - $1.79 Million	-77,121 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$17.03 - $22.67 $1.31 Million - $1.75 Million	77,121 New	77,121 $1.73 Million
Q3 2020 Nov 16, 2020	SELL	$20.67 - $26.94 $294,547 - $383,895	-14,250 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $214,095 - $356,651	-13,007 Reduced 47.72%	14,250 $324,000
Q1 2020 May 14, 2020	SELL	$14.46 - $21.8 $492,203 - $742,050	-34,039 Reduced 55.53%	27,257 $484,000
Q4 2019 Feb 14, 2020	BUY	$15.15 - $18.89 $928,634 - $1.16 Million	61,296 New	61,296 $1.09 Million

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.